{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:38:52Z","timestamp":1776674332741,"version":"3.51.2"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":1418,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1186\/s13613-022-01079-5","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T08:03:44Z","timestamp":1668672224000},"page":"107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with \u03b2-lactams: a prospective multicenter study"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3447-7021","authenticated-orcid":false,"given":"Roman","family":"Mounier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Le Guen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul-Louis","family":"Woerther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Nacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Bonnefon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Mongardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Langeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Couffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Houcke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Roujansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Schimpf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armand","family":"Mekontso Dessap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyvan","family":"Razazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1186\/s13613-022-01079-5_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13613-015-0061-0","article-title":"Mechanisms of antimicrobial resistance in Gram-negative bacilli","volume":"5","author":"Rupp\u00e9","year":"2015","journal-title":"Ann Intensive Care"},{"key":"10.1186\/s13613-022-01079-5_bb0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1186\/s13613-022-01079-5_bb0020","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/jac\/dky084","article-title":"Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC \u03b2-lactamase","volume":"73","author":"Kohlmann","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/s13613-022-01079-5_bb0025","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1086\/423382","article-title":"Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome","volume":"39","author":"Kang","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1186\/s13613-022-01079-5_bb0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1592\/phco.27.2.191","article-title":"Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii","volume":"27","author":"Deal","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"Suppl 2","key":"10.1186\/s13613-022-01079-5_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2165\/00003495-198800352-00004","article-title":"Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A double-blind study","volume":"35","author":"Mich\u00e9a-Hamzehpour","year":"1988","journal-title":"Drugs"},{"key":"10.1186\/s13613-022-01079-5_bb0040","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1086\/517658","article-title":"Rapid emergence of resistance to cefepime during treatment","volume":"26","author":"Acar","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1186\/s13613-022-01079-5_bb0045","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/AAC.01083-07","article-title":"Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use","volume":"52","author":"Choi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/s13613-022-01079-5_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13756-017-0177-0","article-title":"Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case-control study","volume":"6","author":"Harris","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1186\/s13613-022-01079-5_bb0055","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijantimicag.2018.08.007","article-title":"Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin\/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms","volume":"52","author":"McKamey","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1186\/s13613-022-01079-5_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/ajcp\/100.1.47","article-title":"Emergence of antimicrobial resistance in gram-negative bacilli causing bacteremia during therapy","volume":"100","author":"Siebert","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"10.1186\/s13613-022-01079-5_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.015","article-title":"Infections caused by naturally AmpC-producing Enterobacteriaceae: can we use third-generation cephalosporins? A narrative review","volume":"55","author":"Mizrahi","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1186\/s13613-022-01079-5_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2042098614554919","article-title":"Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem","volume":"5","author":"Llor","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"10.1186\/s13613-022-01079-5_bb0075","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.CCM.0000168253.91200.83","article-title":"The international sepsis forum consensus conference on definitions of infection in the intensive care unit","volume":"33","author":"International Sepsis Forum Definition of Infection in the ICU Consensus Conference","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-022-01079-5_bb0080","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"10.1186\/s13613-022-01079-5_bb0085","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1164\/ajrccm.156.4.9701065","article-title":"Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis","volume":"156","author":"Delclaux","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"10.1186\/s13613-022-01079-5_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1469-0691.2007.01856.x","article-title":"Breakpoints for intravenously used cephalosporins in Enterobacteriaceae\u2013EUCAST and CLSI breakpoints","volume":"14","author":"Kahlmeter","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1186\/s13613-022-01079-5_bb0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1186\/s13613-022-01079-5_bb0100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/516294","article-title":"Treatment of ventilator-associated pneumonia with piperacillin-tazobactam\/amikacin versus ceftazidime\/amikacin: a multicenter, randomized controlled trial","volume":"26","author":"Brun-Buisson","year":"1998","journal-title":"VAP Study Group Clin Infect Dis"},{"issue":"649","key":"10.1186\/s13613-022-01079-5_bb0105","first-page":"e1","article-title":"Elaboration of a consensual definition of de-escalation allowing a ranking of \u03b2-lactams","volume":"21","author":"Weiss","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1186\/s13613-022-01079-5_bb0110","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Diagnostics microbiologiques. CASFM \/ EUCAST : Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. 2015;125\u2013326."},{"key":"10.1186\/s13613-022-01079-5_bb0115","first-page":"2282","article-title":"Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime","volume":"68","author":"Jang","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/s13613-022-01079-5_bb0120","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Enterobacteriaceae. CASFM \/ EUCAST : Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. 2018;36\u201344."},{"key":"10.1186\/s13613-022-01079-5_bb0125","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/JCM.02130-10","article-title":"Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae","volume":"49","author":"Garrec","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1186\/s13613-022-01079-5_bb0130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/s12879-014-0647-4","article-title":"Clinical and microbiological characteristics of bloodstream infections due to AmpC \u03b2-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region","volume":"14","author":"Chaubey","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1186\/s13613-022-01079-5_bb0135","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/BF00577747","article-title":"Development of resistance by Enterobacter cloacae during therapy of pulmonary infections in intensive care patients","volume":"72","author":"F\u00fcssle","year":"1994","journal-title":"Clin Investig"},{"key":"10.1186\/s13613-022-01079-5_bb0140","first-page":"CD004267","article-title":"Antibiotics for ventilator-associated pneumonia","volume":"10","author":"Arthur","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1186\/s13613-022-01079-5_bb0145","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1378\/chest.123.4.1208","article-title":"Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study","volume":"123","author":"Blot","year":"2003","journal-title":"Chest"},{"key":"10.1186\/s13613-022-01079-5_bb0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archinte.162.2.185","article-title":"Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species","volume":"162","author":"Cosgrove","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1186\/s13613-022-01079-5_bb0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0924-8579(03)00094-3","article-title":"Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia: an analysis of 249 cases caused by Citrobacter, Enterobacter and Serratia species","volume":"22","author":"Kim","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1186\/s13613-022-01079-5_bb0160","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00365548.2014.954262","article-title":"Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae","volume":"46","author":"Blanchette","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"10.1186\/s13613-022-01079-5_bb0165","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America Guidance on the treatment of AmpC \u03b2-Lactamase-producing Enterobacterales, Carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1186\/s13613-022-01079-5_bb0170","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.3390\/antibiotics9050254","article-title":"Multicenter, observational cohort study evaluating third-generation cephalosporin therapy for bloodstream infections secondary to Enterobacter, Serratia, and Citrobacter species","volume":"9","author":"Derrick","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1186\/s13613-022-01079-5_bb0175","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/cid\/ciu182","article-title":"Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia","volume":"58","author":"Siedner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1186\/s13613-022-01079-5_bb0180","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10096-018-3186-x","article-title":"Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients","volume":"37","author":"de Lastours","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1186\/s13613-022-01079-5_bb0185","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/clinids\/21.5.1107","article-title":"The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms","volume":"21","author":"Jacobson","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1186\/s13613-022-01079-5_bb0190","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","article-title":"Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy","volume":"115","author":"Chow","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1186\/s13613-022-01079-5_bb0195","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JCM.00404-11","article-title":"Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae","volume":"49","author":"Polsfuss","year":"2011","journal-title":"J Clin Microbiol"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-022-01079-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-022-01079-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025006764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025006764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-022-01079-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:41:43Z","timestamp":1776670903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025006764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2110582025006764"],"URL":"https:\/\/doi.org\/10.1186\/s13613-022-01079-5","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with \u03b2-lactams: a prospective multicenter study","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-022-01079-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Author(s) 2022. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"107"}}